Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | CYP2A6 | P11509 | 4/20 | 0.52 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.46 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.42 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.42 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.42 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.42 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.42 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.42 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.42 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.42 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.42 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.42 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.42 |
| ▸ | GPR3 | P46089 | 1/20 | 0.42 |
| ▸ | MAOB | P27338 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11320385 | 0.98 | MAPT (0.52) | MAPTCYP2A6PTGS1PTGS2PKM | |
| Hydrochloric Acid SCHEMBL1237492 | 0.95 | MAPT (0.50) | MAPTCYP2A6PTGS1PTGS2PKM | |
| SCHEMBL3456141 | 0.82 | MAOB (0.49) | MAPTCYP2A6PKMSMN1; SMN2MAOB | |
| SCHEMBL23430404 | 0.75 | CYP2A6 (0.44) | MAPTCYP2A6PTGS1PTGS2PKM | |
| SCHEMBL4381193 | 0.74 | CYP2A6 (0.54) | MAPTCYP2A6PKMHDAC3HDAC4 | |
| SCHEMBL21338369 | 0.73 | TNKS2 (0.44) | MAPTCYP2A6SMN1; SMN2ALDH1A1ALOX5 | |
| SCHEMBL18805431 | 0.73 | CYP2A6 (0.50) | MAPTCYP2A6PTGS1PTGS2CYP1A2 | |
| SCHEMBL20751462 | 0.72 | CYP2A6 (0.51) | MAPTCYP2A6SMN1; SMN2ALDH1A1TP53 | |
| SCHEMBL15472198 | 0.72 | PKM (0.51) | MAPTPKMSMN1; SMN2ALDH1A1TP53 | |
| SCHEMBL264791 | 0.72 | CYP2A6 (0.52) | MAPTCYP2A6PKMSMN1; SMN2HDAC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1919 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4129065-B1 | MAMMAL REPELLENT | SCENT SCIENCE INT INC (JP) | 2025-06-11 | — | — | EP | claimed |
| CN-118496887-A | Method for removing sulfur-containing organic compounds in oil products by using porous carbon nano-sheet supported bimetallic phosphide catalyst | 广东石油化工学院 | 2024-08-16 | — | — | CN | claimed |
| CN-115851377-B | Extraction method for improving quality of Pterocarpus marsupium essential oil and application | 江西省林业科学院 | 2024-06-25 | — | — | CN | claimed |
| CN-117700750-A | Preparation method of functional polysiloxane with atypical fluorescence | 山东大学 | 2024-03-15 | — | — | CN | claimed |
| CN-117700440-A | Preparation method of functional disiloxane with atypical fluorescence | 山东大学 | 2024-03-15 | — | — | CN | claimed |
| US-20230363389-A1 | MAMMAL REPELLENT | SCENT SCIENCE INTERNATIONAL INC. (JP) | 2023-11-16 | — | — | US | claimed |
| EP-4247837-A1 | NEW CYCLIC COMPOUNDS, PROCESS FOR THE PRODUCTION THEREOF, AND USE OF SAID CYCLIC COMPOUNDS IN COSMETIC PREPARATIONS | Eberhard-Karls-Universität Tübingen (DE) | 2023-09-27 | — | — | EP | claimed |
| CN-116704872-A | Preparation method of surface-enhanced Raman label | 南京工业大学 | 2023-09-05 | — | — | CN | claimed |
| CN-116640106-A | Phenylpiperazine compound and preparation method and application thereof | 郑州大学 | 2023-08-25 | — | — | CN | claimed |
| CN-116635400-A | Novel cyclic compounds, method for the production thereof and use of these cyclic compounds in cosmetic preparations | 艾伯哈特卡尔斯图宾根大学 | 2023-08-22 | — | — | CN | claimed |
| US-5169841-A | Enzyme inhibitors, hypotensive agents, high enteral bioauailability | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-12-08 | — | — | US | claimed |
| US-5104869-A | Renin inhibitors | AMERICAN CYANAMID COMPANY (US) | 1992-04-14 | — | — | US | claimed |
| EP-0460679-A2 | Endothelin antagonistic peptide derivatives | Banyu Pharmaceutical Co., Ltd. (JP) | 1991-12-11 | — | — | EP | claimed |
| EP-0435059-A1 | Retroviral protease inhibitors | HOECHST AKTIENGESELLSCHAFT (DE) | 1991-07-03 | — | — | EP | claimed |
| EP-0428849-A2 | Retroviral protease inhibitors | HOECHST AKTIENGESELLSCHAFT (DE) | 1991-05-29 | — | — | EP | claimed |
| EP-0427939-A2 | Renin inhibitors | AMERICAN CYANAMID COMPANY (US) | 1991-05-22 | — | — | EP | claimed |
| EP-0371467-A2 | Beta-amino boron acid derivatives | HOECHST AKTIENGESELLSCHAFT (DE) | 1990-06-06 | — | — | EP | claimed |
| EP-0354522-A1 | Use of alpha-aminoboronic acid derivatives in prevention and treatement of viral diseases | HOECHST AKTIENGESELLSCHAFT (DE) | 1990-02-14 | — | — | EP | claimed |
| EP-0315574-A2 | Renin inhibitors | HOECHST AKTIENGESELLSCHAFT (DE) | 1989-05-10 | — | — | EP | claimed |
| EP-0050072-B1 | CYCLOPROPYL METHYL PIPERAZINES, PROCESS FOR THEIR PREPARATION AND THEIR USE IN THERAPEUTICS | INNOTHERA (FR) | 1984-12-27 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230363389-A1 | MAMMAL REPELLENT | TMT1A, L3MBTL1, NAAA | MAPT 2855/4885CYP2A6 699/4885PTGS1 3356/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.